BVT Call 3.8 NOA3 20.06.2024/ DE000VU6G8J0 /
03.06.2024 8:52:09 | Изменение+0.001 | Бид14:38:08 | Предложение14:38:08 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.029EUR | +3.57% | 0.075 Величина цены спроса: 112,000 |
0.094 Величина цены предложения: 112,000 |
NOKIA OYJ EO-,06 | 3.80 EUR | 20.06.2024 | Call |
GlobeNewswire
14:54
SRCL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Stericycle to Waste...
Newsfile Corp
14:45
Bassett Furniture Industries, Inc. to Present at Water Tower Research's Inaugural Consumer Products ...
GlobeNewswire
14:42
EXL named a Leader in 2024 Gartner® Magic Quadrant™ for Finance and Accounting Business Process Outs...
GlobeNewswire
14:38
Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tu...
GlobeNewswire
14:35
IBN Announces Latest Episode of The Stock2Me Podcast featuring Brian J. Esposito, CEO of Diamond Lak...
GlobeNewswire
14:31
German American Bancorp, Inc. announces the sale of the assets of German American Insurance, Inc. to...
Newsfile Corp
14:30
GoGold Resources Inc. to Participate in THE Mining Investment Event of the North, Canada's Only Tier...
GlobeNewswire
14:30
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce...
GlobeNewswire
14:30
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives...
GlobeNewswire
14:30
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placement...
GlobeNewswire
14:30
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
GlobeNewswire
14:30
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Cli...
GlobeNewswire
14:30
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
GlobeNewswire
14:30
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
GlobeNewswire
14:20
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница